EMEA-001129-PIP01-11-M06 - paediatric investigation plan

peginterferon beta-1a
PIPHuman

Key facts

Invented name
Plegridy
Active Substance
peginterferon beta-1a
Therapeutic area
Neurology
Decision number
P/0419/2023
PIP number
EMEA-001129-PIP01-11-M06
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
  • Subcutaneous use
  • Intramuscular use
Contact for public enquiries

Biogen Idec Ltd

Tel. +44 (0)1628 501000
E-mail: pip.enquiries@biogen.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page